We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

BONE GLUE MARKET ANALYSIS

Bone Glue Market, by Product Type (Synthetic Bone Glue and Natural Bone Glue), by Therapeutic Application (Osteoporosis, Sports Injuries, Spinal Injuries, Traumatic Bone Fracture, and Bone Tumor), by End User (Hospitals, Clinics, Specialized Orthopedic Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Aug 2022
  • Code : CMI242
  • Pages :196
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market News

Global Bone Glue Market: Key Developments

  • In November 2021, a report was published in Frontiers in Bioengineering and Biotechnology, A multidisciplinary journal, on gluing living bone using a biomimetic bioadhesive: from initial cut to final healing, which reported that the OsStic adhesive harmonizes with the local bone biology in the murine bone core model with no signs of inflammation or adverse tissue effects throughout the study. The sticky layer is replaced by bone multicellular units throughout the healing of the sliced bone core surfaces, and by 42 days, the cortical and cancellous compartments of the bone have recovered up to 50% and 70% of their original quality and quantity.
  • For instance, in December 2021, icotec ag, a medical device manufacturer of Carbon/PEEK implants company, strategically corporates with G-21, medical and pharmaceutical sector company, to distribute their bone cements in conjunction with icotec's VADER Pedicle Screw System in the U.S. The VADER Pedicle System is intended to restore the integrity of the spinal column even in the absence of fusion in patients with advanced stage tumors involving the thoracic or lumbar spine in whom life expectance, prior to oncological treatment, is of insufficient duration to permit achievement of fusion.
  • For instance, in December 2020, Smith & Nephew, a multinational medical equipment manufacturing company, started a field action to remove one batch of Versabond AB 40 Grams Formulation 2 due to possible exposure to heat and humidity, Smith & Nephew started a field action to remove one batch of Versabond AB 40 Grams Formulation. When mixed, the impacted lot was said to have an unusually sand-like, flaky, or gritty consistency. VERSABOND is a medium viscosity bone cement which can be used for hip, knee, and shoulder implant fixation with superior handling and mechanical properties.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.